Polar Recognition Group Study of Keap1-Nrf2 Protein–Protein Interaction Inhibitors

Eitemau Tebyg

• An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis
  gan: Lu, Meng-Chen, et al.
  Cyhoeddwyd: (2016)
• CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation
  gan: Lu, Meng-Chen, et al.
  Cyhoeddwyd: (2019)
• Discovery of Keap1−Nrf2 small−molecule inhibitors from phytochemicals based on molecular docking
  gan: Li, Maiquan, et al.
  Cyhoeddwyd: (2019)
• Emerging Screening Approaches in the Development of Nrf2–Keap1 Protein–Protein Interaction Inhibitors
  gan: Leung, Chung-Hang, et al.
  Cyhoeddwyd: (2019)
• Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction
  gan: Inoyama, Daigo, et al.
  Cyhoeddwyd: (2011)